Annual CFO
-$1.93 M
-$1.85 M-2286.26%
March 31, 2024
Summary
- As of February 8, 2025, SXTC annual cash flow from operations is -$1.93 million, with the most recent change of -$1.85 million (-2286.26%) on March 31, 2024.
- During the last 3 years, SXTC annual CFO has fallen by -$611.50 thousand (-46.45%).
- SXTC annual CFO is now -200.41% below its all-time high of $1.92 million, reached on March 31, 2018.
Performance
SXTC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SXTC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2286.3% | - | - |
| 3 y3 years | -46.5% | - | - |
| 5 y5 years | -906.1% | - | - |
SXTC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -818.6% | at low | ||||
| 5 y | 5-year | -306.4% | at low | ||||
| alltime | all time | -200.4% | at low |
China SXT Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$1.93 M(+2286.3%) | - | - |
| Mar 2023 | -$80.80 K(-130.1%) | - | - |
| Mar 2022 | $268.30 K(-120.4%) | - | - |
| Mar 2021 | -$1.32 M(-240.9%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | $934.20 K(+290.6%) | - | - |
| Mar 2019 | $239.20 K(-87.5%) | - | - |
| Mar 2018 | $1.92 M(+555.4%) | - | - |
| Mar 2017 | $293.00 K | - | - |
FAQ
- What is China SXT Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual CFO year-on-year change?
What is China SXT Pharmaceuticals annual cash flow from operations?
The current annual CFO of SXTC is -$1.93 M
What is the all time high annual CFO for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual cash flow from operations is $1.92 M
What is China SXT Pharmaceuticals annual CFO year-on-year change?
Over the past year, SXTC annual cash flow from operations has changed by -$1.85 M (-2286.26%)